MEDIFAST (MED)
(Delayed Data from NYSE)
$19.16 USD
-0.72 (-3.62%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.20 +0.04 (0.21%) 7:04 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.16 USD
-0.72 (-3.62%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.20 +0.04 (0.21%) 7:04 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Zacks News
Hormel Foods' (HRL) Planters Snacking Business Buyout to Aid Growth
by Zacks Equity Research
Hormel Foods (HRL) acquires Planters snacking portfolio from The Kraft Heinz Company. The buyout will enhance the snacking portfolio.
Clorox (CLX) Expands Portfolio With Hamilton Beach Deal
by Zacks Equity Research
Clorox (CLX) to expand its surface and air disinfecting products through its latest multi-year licensing deal with Hamilton Beach Brands. Also, this is in line with the company's IGNITE plan.
SpartanNash's (SPTN) Q1 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts mixed results for the first quarter of 2021. The company's segmental sales decline weighs on the overall top line.
What Makes Medifast (MED) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Medifast (MED) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Is Medifast (MED) Up 27.6% Since Last Earnings Report?
by Zacks Equity Research
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Down
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2021 results reflect lower sales and earnings thanks to weakness across most segments. Nevertheless, sustained demand for at-home food was an upside.
Medifast (MED) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Medifast (MED) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here's Why You Must Add Newell Brands (NWL) to Your Portfolio
by Zacks Equity Research
Although cost woes remain concerns, robust consumption patterns, higher demand and a solid online show are likely to aid Newell Brands (NWL).
Tyson Foods (TSN) Offers Plant-Based Products in Asia Pacific
by Zacks Equity Research
Tyson Foods' (TSN) is launching a range of plant-based products in chosen retail markets and digital platforms in Asia Pacific under First Pride brand.
Pilgrim's Pride (PPC) Gains on Capacity Growth, Mexico Unit
by Zacks Equity Research
Pilgrim's Pride (PPC) gains from capacity expansions for key products. Also, solid operations in Mexico and revival of market conditions in the United States are upsides.
Mondelez's (MDLZ) Chipita Buyout to Boost Presence in Europe
by Zacks Equity Research
Mondelez (MDLZ) announces a deal to acquire the producer of sweet and salty snacks, Chipita, which will boost its presence in Central and Eastern Europe.
Sanderson Farms (SAFM) Q2 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
Sanderson Farms' (SAFM) Q2 results reflect gains from improved demand for poultry products.
Medifast (MED) Looks Appetizing, OPTAVIA Solution a Key Upside
by Zacks Equity Research
Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system. Additionally, the company has been speeding up its long-term supply-chain efforts.
The Zacks Analyst Blog Highlights: Medifast, Tenneco, Dillard's, Olin Corp and PDC Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medifast, Tenneco, Dillard's, Olin Corp and PDC Energy
5 High-Flying Growth Stocks to Buy Despite Inflation Concern
by Nalak Das
We have narrowed down our search to five growth stocks that have popped more than 10% in the past month. These are; MED, TEN, DDS, OLN and PDCE.
3 Reasons Growth Investors Will Love Medifast (MED)
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
How to Find Strong Buy Consumer Staples Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Kraft Heinz (KHC) Poised on Solid Operating Model, Pricing Efforts
by Zacks Equity Research
Kraft Heinz (KHC) is committed to its operating model, which was laid out in September 2020. Also, solid pricing initiatives have been aiding growth.
Kellogg (K) Gains More Than 10% in 3 Months: Will Growth Stay?
by Zacks Equity Research
Kellogg Company (K) looks well placed on the back of high demand for packaged foods amid the pandemic. Certainly, the company's brand strength has been a driver.
Sysco (SYY) Unveils Recipe for Growth, Offers Financial Targets
by Zacks Equity Research
Sysco (SYY) talks about Recipe for Growth at its 2021 Investor Day, which highlights its five strategic pillars. Also, it enters a deal to acquire Greco and Sons.
Flowers Foods (FLO) Q1 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Flowers Foods' (FLO) first-quarter fiscal 2021 earnings are flat year over year. Moreover, sales decline due to weakness in branded retail and store branded retail categories.
Hormel Foods' (HRL) Q2 Earnings Match Estimates, Sales Grow Y/Y
by Vrishali Bagree
Hormel Foods' (HRL) second-quarter fiscal 2021 results reflect a solid foodservice business, as well as high retail, deli and international demand. Management raises sales view.
If You Invested $1000 in Medifast 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Can the Rally in Medifast (MED) Shares Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of Medifast (MED)
The Estee Lauder Companies (EL) Ups DECIEM Stake, Boosts Skincare
by Zacks Equity Research
The Estee Lauder Companies (EL) now has nearly 76% ownership in DECIEM compared with 29% earlier. This is likely to fuel its skincare business.